Size-dependent antimicrobial effects of novel palladium nanoparticles.
Investigating the interactions between nanoscale materials and microorganisms is crucial to provide a comprehensive, proactive understanding of nanomaterial toxicity and explore the potential for novel applications. It is well known that nanomaterial behavior is governed by the size and composition of the particles, though the effects of small differences in size toward biological cells have not been well investigated. Palladium nanoparticles (Pd NPs) have gained significant interest as catalysts for important carbon-carbon and carbon-heteroatom reactions and are increasingly used in the chemical industry, however, few other applications of Pd NPs have been investigated. In the present study, we examined the antimicrobial capacity of Pd NPs, which provides both an indication of their usefulness as target antimicrobial compounds, as well as their potency as potential environmental pollutants. We synthesized Pd NPs of three different well-constrained sizes, 2.0 ± 0.1 nm, 2.5 ± 0.2 nm and 3.1 ± 0.2 nm. We examined the inhibitory effects of the Pd NPs and Pd(2+) ions toward gram negative Escherichia coli (E. coli) and gram positive Staphylococcus aureus (S. aureus) bacterial cultures throughout a 24 hour period. Inhibitory growth effects of six concentrations of Pd NPs and Pd(2+) ions (2.5 × 10(-4), 10(-5), 10(-6), 10(-7), 10(-8), and 10(-9) M) were examined. Our results indicate that Pd NPs are generally much more inhibitory toward S. aureus than toward E. coli, though all sizes are toxic at ≥ 10(-5) M to both organisms. We observed a significant difference in size-dependence of antimicrobial activity, which differed based on the microorganism tested. Our work shows that Pd NPs are highly antimicrobial, and that fine-scale (<1 nm) differences in size can alter antimicrobial activity.
Department of Chemistry, Western Michigan University, Kalamazoo, Michigan, United States of America.
Clara P
CP
Adams
Department of Biological Sciences, Western Michigan University, Michigan, United States of America.
Katherine A
KA
Walker
Department of Chemistry, Western Michigan University, Kalamazoo, Michigan, United States of America.
Sherine O
SO
Obare
Department of Biological Sciences, Western Michigan University, Michigan, United States of America.
Kathryn M
KM
Docherty
D000900:Anti-Bacterial Agents / Q000737:chemistry* / Q000494:pharmacology*; D004926:Escherichia coli / Q000187:drug effects*; D004927:Escherichia coli Infections / Q000188:drug therapy; D006801:Humans; D053768:Metal Nanoparticles / Q000737:chemistry* / Q000648:ultrastructure; D008826:Microbial Sensitivity Tests; D010165:Palladium / Q000737:chemistry* / Q000494:pharmacology*; D010316:Particle Size; D013203:Staphylococcal Infections / Q000188:drug therapy; D013211:Staphylococcus aureus / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D010165:Palladium